Cite
HARVARD Citation
Mishra, A. et al. (2022). Inhibition of the endosomal recycling pathway downregulates HER2 activation and overcomes resistance to tyrosine kinase inhibitors in HER2-positive breast cancer. Cancer letters. pp. 153-167. [Online].